Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human

References

• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet. 2012;379:815–822
   PubMed Web of Science ®Google Scholar
• Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284
   PubMed Web of Science ®Google Scholar
• Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
   PubMed Web of Science ®Google Scholar
• Liu H, Peng Y, Li J, et al. Stages of 3547 patients with chronic kidney disease and relevant factor analysis. Cent South Univ (Med Sci). 2010;35:499–510
   Google Scholar
• Fassett RG, Venuthurupalli SK, Gobe GC, et al. Biomarkers in chronic kidney disease. Kidney Int. 2011;80:806–821
   PubMed Web of Science ®Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:337–344
   PubMed Web of Science ®Google Scholar
• Zhu C, Huang S, Ding G, et al. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats. Pediatr Nephrol. 2011;26:905–913
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
   PubMed Web of Science ®Google Scholar
• Lysaght MJ. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol. 2002;13:S37–S40
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
   PubMed Web of Science ®Google Scholar
• Garg AX, Kiberd BA, Clark WF, et al. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES_III. Kindney Int. 2002;61:2165–2175
   PubMed Web of Science ®Google Scholar
• Iseki K. The okinawa screening program. J Am Soc Nephrol. 2003;7(Suppl. 2):127–130
   Google Scholar
• Li PK, Kwan BC, Leung CB. Prevalence of silent kidney disease in Hong Kong: The Screening for Hong Kong Asymtomatic Renal Population and Valuation (SHARE) program. Kidney Int. 2005;67(Suppl. 94):S36–S40
   Google Scholar
• Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048–1056
   PubMed Web of Science ®Google Scholar
• Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Kidney disease: Improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, Bökenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem. 2007;40:946–951
   PubMed Web of Science ®Google Scholar
• Shen SJ, Hu ZX, Li QH, et al. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease. Nephrology (Carlton). 2014;19(3):129–135
   Google Scholar
• Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous marker of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000;54:203–209
   PubMed Web of Science ®Google Scholar
• Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2006;15:610–616
   PubMed Web of Science ®Google Scholar
• Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312–318
   PubMed Web of Science ®Google Scholar
• Spanaus KS, Kollerits B, Ritz E, et al. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem. 2010;56:740–749
   PubMed Web of Science ®Google Scholar
• Maeshima E, Liang XM, Goda M, Otani H, Mune M. The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: A preliminary study. Clin Rheumatol. 2007;26:401–404
   PubMed Web of Science ®Google Scholar
• Taal MW, Brenner BM. Renal risk scores: Progress and prospects. Kidney Int. 2008;73:1216–1219
   PubMed Web of Science ®Google Scholar
• Taler SJ, Agarwal R, Bakris GL, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013;62(2):201–213
   PubMed Web of Science ®Google Scholar
• Braun L, Sood V, Hogue S, Lieberman B, Copley-Merriman C. High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis. 2012;5:151–163
   PubMedGoogle Scholar
• Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23(2):194–200
   Google Scholar
• Zhang B, Ni N, Wu YB, Zheng LH. Effect of Huai qi huang particles on serum TNF-α, IL-18 and IL-10 in children with primary nephrotic syndrome. Chinese J Pract Pediatr. 2010;25(1):33–36
   Google Scholar